Eris Lifesciences Limited (ERIS.NS) NSE

1,545.00

-7(-0.45%)

Updated at December 24 03:29PM

Currency In INR

Valuation

Market Cap189.48B
Enterprise Value212.03B
P/E Ratio50.65
PEG Ratio6.89
Price/Sales Ratio7.05
Price/Book Ratio6.81
Enterprise/Revenue7.83
Enterprise/EBITDA21.64

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.14
Operating Margin0.34

Management Effectiveness

Return On Assets0.06
Return On Equity0.13

Income Statement

Revenue28.79B
Revenue/Share219.16
Gross Profit21.49B
EBITDA10.17B
Net Income3.52B
Diluted EPS25.81

Balance Sheet

Total Cash839.2M
Total Cash/Share6.16
Total Debt23.89B
Total Debt/Equity0.77
Current Ratio0.91
Book Value Per Share257.1

Price History

52-Week Change15.11
52-Week High1,910
52-Week Low1,097.2
Moving Average 50 Days1,593.27
Moving Average 200 Days1,600.11

Statistics

Average Volume152,038
Shares Outstanding136.22M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate7.35
Trailing Annual Dividend Yield0.48
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A